Skip to content

Standard HIV treatment achieves high concentrations in female genital tract and suppresses shedding of virus

Risk score can help predict which people living with HIV have highest risk of kidney disease during tenofovir treatment

South African treatment guidelines need to consider viral load, not CD4 count, to achieve greater impact of treatment as prevention: study

Early treatment reduces viral reservoirs but does not prevent rebound

Afam Okoye, from the Vaccine and Gene Therapy Institute in Florida and the Oregon Health and Science University, presenting at CROI 2014. Photo by Liz Highleyman, hivandhepatitis.com.

Early antiretroviral therapy may limit gut damage and immune activation

Very different levels of PrEP uptake and adherence in three US cities, demonstration project finds

Heart attack link to abacavir persists in D:A:D study

After 2008, fewer people at high risk of a heart attack were prescribed abacavir, but the appararent link to the drug remains. Image credit: Caroline Sabin / D:A:D study.

Efavirenz-based ART matches lopinavir/ritonavir for perinatal HIV treatment

New NNRTI doravirine matches efavirenz for first-line HIV treatment

Javier Morales-Ramirez presenting at CROI 2014. Photo by Liz Highleyman, hivandhepatitis.com.